| Thyroid hormone signaling pathway |
15 |
8.3E-4 |
1.7E-1 |
Signaling pathways regulating pluripotency of stem cells |
15 |
1.5E-4 |
3.1E-2 |
| Transcriptional misregulation in cancer |
18 |
9.9E-4 |
1.1E-1 |
Pathways in cancer |
26 |
9.5E-4 |
9.7E-2 |
| Protein digestion and absorption |
12 |
1.9E-3 |
1.3E-1 |
Transcriptional misregulation in cancer |
15 |
1.3E-3 |
8.8E-2 |
| Pathways in cancer |
32 |
3.2E-3 |
1.6E-1 |
FoxO signaling pathway |
12 |
3.3E-3 |
1.6E-1 |
| Endocytosis |
23 |
3.5E-3 |
1.5E-1 |
AMPK signaling pathway |
11 |
5.5E-3 |
2.1E-1 |
| Neurotrophin signaling pathway |
14 |
3.9E-3 |
1.4E-1 |
RNA degradation |
8 |
9.9E-3 |
3.0E-1 |
| Ras signaling pathway |
20 |
7.2E-3 |
2.1E-1 |
mRNA surveillance pathway |
9 |
1.0E-2 |
2.8E-1 |
| Glycosaminoglycan biosynthesis-chondroitin sulfate / dermatan sulfate |
5 |
1.3E-2 |
3.1E-1 |
GABAergic synapse |
8 |
1.7E-2 |
3.7E-1 |
| Ubiquitin mediated proteolysis |
14 |
1.3E-2 |
2.8E-1 |
TGF-beta signaling pathway |
8 |
1.9E-2 |
3.7E-1 |
| miRNAs in cancer |
14 |
1.4E-2 |
2.7E-1 |
MAPK signaling pathway |
16 |
2.1E-2 |
3.7E-1 |
| Vasopressin-regulated water reabsorption |
7 |
1.5E-2 |
2.6E-1 |
ErbB signaling pathway |
8 |
2.1E-2 |
3.4E-1 |
| MAPK signaling pathway |
20 |
2.8E-2 |
4.1E-1 |
Rap1 signaling pathway |
14 |
2.2E-2 |
3.3E-1 |
| AMPK signaling pathway |
12 |
2.9E-2 |
4.0E-1 |
MicroRNAs in cancer |
16 |
2.3E-2 |
3.2E-1 |
| Renal cell carcinoma |
8 |
3.3E-2 |
4.2E-1 |
PI3K-Akt signaling pathway |
19 |
2.9E-2 |
3.6E-1 |
| Focal adhesion |
17 |
3.6E-2 |
4.2E-1 |
GnRH signaling pathway |
8 |
3.5E-2 |
3.9E-1 |
| Dorso-ventral axis formation |
5 |
3.7E-2 |
4.1E-1 |
Estrogen signaling pathway |
8 |
3.5E-2 |
3.9E-1 |
| Regulation of actin cytoskeleton |
17 |
4.0E-2 |
4.2E-1 |
Ubiquitin mediated proteolysis |
10 |
3.8E-2 |
4.1E-1 |
| Insulin secretion |
9 |
4.7E-2 |
4.5E-1 |
Neurotrophin signaling pathway |
9 |
4.7E-2 |
4.5E-1 |
